Moleculin Biotech (MBRX) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts MBRX Hot Sheet
Join SI Premium – FREE
Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.19), $0.03 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ennis (EBF) Reports In-Line Q1 EPS
- Accenture downgraded by TD Cowen on AI concerns
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
